Kirsten Drejer, PhD takes on the role as Chairwoman of the Board of ResoTher Pharma following a unanimous vote at the company´s general assembly. “We are extremely pleased with the collaboration with Kirsten, who has a wealth of experience to contribute to a company such as ours. She is smart, engaged and understands the science, which allows her to challenge our assumptions. We look forward to the next phase of our development with Kirsten at the helm” states former Chairman and co-founder Jeppe Øvlesen.